These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20542801)

  • 1. Optical coherence tomography for the assessment of pericardium covered stents for the treatment of degenerated saphenous vein grafts.
    Tyczynski P; Kukreja N; van Geuns RJ; Wykrzykowska JJ; Sheppard MN; Di Mario C
    EuroIntervention; 2010 May; 6(1):78-85. PubMed ID: 20542801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distal embolization after net protective stent (MGUARD) implantation in a degenerated saphenous vein graft lesion.
    Yassin I; Thuesen L
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):639-41. PubMed ID: 20091812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.
    Badhey N; Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Addo TA; Haagen D; Abdel-Karim AR; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger PB; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):263-9. PubMed ID: 20665875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
    Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Holper EM; Haagen D; Saeed B; Iturbe JM; Shunk K; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
    JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous saphenous vein graft intervention with sequential embolic protection devices: complementing lesion anatomy with embolic protection device.
    Grow P; Rab ST
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):636-40. PubMed ID: 18942125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
    Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
    JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection.
    Ashby DT; Dangas G; Aymong EA; Iakovou I; Kuepper F; Mehran R; Stone GW; Leon MB; Moses JW
    J Am Coll Cardiol; 2003 Mar; 41(5):749-52. PubMed ID: 12628717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications and immediate and long-term results of a novel pericardium covered stent graft: Consecutive 5 year single center experience.
    Secco GG; Serdoz R; Kilic ID; Caiazzo G; Mattesini A; Parisi R; De Luca G; Pistis G; Marino PN; Di Mario C
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):712-9. PubMed ID: 26541909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous intervention of a thrombotic-occluded saphenous vein graft successfully treated using the undersized stent approach to prevent distal embolization.
    Maluenda G; Alfonso F; Pichard AD
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):65-9. PubMed ID: 21328690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the Proxis embolic protection device for guide anchoring and stent delivery during complex saphenous vein graft interventions.
    Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2009; 10(3):183-7. PubMed ID: 19595401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tirofiban administration and percutaneous coronary intervention with stenting of saphenous vein graft thrombosis.
    D'andrea C; Esposito G; Piscione F; Chiariello M
    J Cardiovasc Med (Hagerstown); 2009 Nov; 10(11):875-8. PubMed ID: 19644385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique stenosis in saphenous vein graft visualized by optical coherence tomography.
    Koeda Y; Itoh T; Fusazaki T; Nakamura M; Morino Y
    Heart Vessels; 2014 Mar; 29(2):278-81. PubMed ID: 23712599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedural results and distal embolization after saphenous vein graft stenting and angioplasty for in-stent restenosis of grafts.
    Cicek D; Doven O; Pekdemir H; Camsari A; Akkus NM; Cin GV; Parmaksiz T; Katircibasi T
    Jpn Heart J; 2004 Jul; 45(4):561-71. PubMed ID: 15353867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radial stent deformation in saphenous vein graft.
    Sachdeva R; Aleti S; Thai H
    EuroIntervention; 2012 Nov; 8(7):876-7. PubMed ID: 23171807
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy.
    Kirtane AJ; Heyman ER; Metzger C; Breall JA; Carrozza JP
    JACC Cardiovasc Interv; 2008 Apr; 1(2):186-91. PubMed ID: 19463299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCI in severely degenerated saphenous vein graft using a novel mesh-covered stent together with a conventional embolic protection system.
    Dimopoulos AK; Manginas A; Pavlides G; Cokkinos DV
    Hellenic J Cardiol; 2009; 50(5):429-35. PubMed ID: 19767288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a self-expanding super-elastic all-metal endoprosthesis; to treat degenerated SVG lesions: the SESAME first in man trial.
    Abizaid A; Weiner B; Bailey SR; Londero H
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):781-6. PubMed ID: 20549692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device?
    Okabe T; Lindsay J; Torguson R; Steinberg DH; Roy P; Slottow TL; Kaneshige K; Xue Z; Satler LF; Kent KM; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):799-803. PubMed ID: 19006243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial.
    Latif F; Uyeda L; Edson R; Bhatt DL; Goldman S; Holmes DR; Rao SV; Shunk K; Aggarwal K; Uretsky B; Bolad I; Ziada K; McFalls E; Irimpen A; Truong HT; Kinlay S; Papademetriou V; Velagaleti RS; Rangan BV; Mavromatis K; Shih MC; Banerjee S; Brilakis ES
    Circ Cardiovasc Interv; 2020 Feb; 13(2):e008494. PubMed ID: 32019343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary experiences using the MGuard stent platform in saphenous vein graft lesions.
    Vaknin-Assa H; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1055-7. PubMed ID: 19434749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.